CompletedPhase 1ACTRN12605000517673
A randomised, two-way crossover study to compare the pharmacokinetics of testosterone following application of a Testosterone Metered Dose (MD) lotion or AndroGel in men with low serum testosterone
Sponsor
Acrux DDS Pty Ltd
Enrollment
6 participants
Start Date
Feb 1, 2004
Study Type
Interventional
Conditions
Eligibility
Sex: Males
Inclusion Criteria1
- Hypoandrogenic males, who were otherwise healthy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Testosterone Metered Dose (MD) lotion and AndroGel, single doses (i.e. for one day each).
Testosterone Metered Dose (MD) lotion and AndroGel, single doses (i.e. for one day each).
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000517673
Related Trials
Inherited Reproductive Disorders
NCT015004472 locations
Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality
NCT075464351 location
Observation of Environment and Reproductive-Endocrine Effects
NCT062808071 location
Adaptions and Resiliency to Multi-Stressor OpeRations
NCT064559691 location
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
NCT062472671 location